Press Release | LA-based biotech firm led by Dr. Leen Kawas, Richard Kayne closes new $100M fund

Propel Bio Partners just closed a $100 million fund, a milestone that reflects the firm's growing conviction that late-stage biotech assets need more than capital to cross the finish line. Led by Dr. Leen Kawas and Richard Kayne, the Los Angeles-based venture/incubator hybrid pairs funding with hands-on clinical, regulatory, and commercialization support for companies developing therapies in rare disease, infectious disease, and oncology. The full press release details their model and what it means for the next phase of the firm's growth.

Read the Full Article Here